Beverley Shea

40.0k total citations · 5 hit papers
217 papers, 25.4k citations indexed

About

Beverley Shea is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Statistics, Probability and Uncertainty. According to data from OpenAlex, Beverley Shea has authored 217 papers receiving a total of 25.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Rheumatology, 36 papers in Orthopedics and Sports Medicine and 36 papers in Statistics, Probability and Uncertainty. Recurrent topics in Beverley Shea's work include Rheumatoid Arthritis Research and Therapies (38 papers), Meta-analysis and systematic reviews (36 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). Beverley Shea is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (38 papers), Meta-analysis and systematic reviews (36 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). Beverley Shea collaborates with scholars based in Canada, United States and United Kingdom. Beverley Shea's co-authors include George A. Wells, Peter Tugwell, Candyce Hamel, Vivian Welch, David Moher, Barnaby C Reeves, David Henry, Elizabeth Kristjansson, Maarten Boers and Micere Thuku and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Beverley Shea

208 papers receiving 24.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

2017 6.7k citations Beverley Shea, George A. Wells et al. profile →
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

2007 3.3k citations Beverley Shea, George A. Wells et al. profile →
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

2009 1.4k citations Beverley Shea, George A. Wells et al. profile →
ROBIS: A new tool to assess risk of bias in systematic reviews was developed

2015 1.4k citations Beverley Shea et al. profile →
Exercise for preventing and treating osteoporosis in postmenopausal women

2011 647 citations Beverley Shea et al. Cochrane Database of Systematic Reviews profile →

Peers

Countries citing papers authored by Beverley Shea

Since Specialization

Citations

This map shows the geographic impact of Beverley Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverley Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverley Shea more than expected).

Fields of papers citing papers by Beverley Shea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverley Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverley Shea. The network helps show where Beverley Shea may publish in the future.

Co-authorship network of co-authors of Beverley Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Beverley Shea. A scholar is included among the top collaborators of Beverley Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverley Shea. Beverley Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023 2024 ·Seminars in Arthritis and Rheumatism ·Beverley Shea, Jordi Pardo Pardo, (unknown), Dorcas Beaton, Philip G. Conaghan, Wim Goettsch, Catherine Hofstetter, Lara Maxwell, (unknown), Daniel A. Ollendorf, (unknown), Randall M. Stevens, Vibeke Strand, Peter Tugwell, Paula Williamson, Sean Tunis, Lee S. Simon	0
2	Exploring decision-makers’ challenges and strategies when selecting multiple systematic reviews: insights for AI decision support tools in healthcare 2024 ·BMJ Open ·Carole Lunny, Sera Whitelaw, Emma K. Reid, (unknown), (unknown), (unknown), Dawid Pieper, Salmaan Kanji, Areti‐Angeliki Veroniki, Beverley Shea, (unknown), Clare L. Ardern, Ba’ Pham, Ebrahim Bagheri, Andrea C. Tricco	2
3	Protocol for the development of a reporting guideline for umbrella reviews on epidemiological associations using cross-sectional, case-control and cohort studies: the Preferred Reporting Items for Umbrella Reviews of Cross-sectional, Case-control and Cohort studies (PRIUR-CCC) 2024 ·BMJ Open ·Marco Solmi, Kelly D. Cobey, David Moher, Sanam Ebrahimzadeh, Elena Dragioti, Jae Il Shin, Joaquim Raduà, Samuele Cortese, Beverley Shea, Nicola Veronese, Lisa Hartling, Michelle Pollock, Matthias Egger, Stefania Papatheodorou, John P. A. Ioannidis, André F. Carvalho	5
4	The use of virtual nominal groups in healthcare research: An extended scoping review 2024 ·PLoS ONE ·Seung Ho Lee, Olle ten Cate, Michael Gottlieb, Tanya Horsley, Beverley Shea, Karine Fournier, Christopher Tran, Teresa M. Chan, Timothy J. Wood, Susan Humphrey‐Murto	4
5	Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol 2023 ·Trials ·(unknown), Anthony C. Redmond, Caroline Flurey, Pamela Richards, Toby O. Smith, John B. Arnold, Dorcas Beaton, Philip G. Conaghan, Yvonne M. Golightly, Marian T. Hannan, Catherine Hofstetter, Lara Maxwell, Hylton B. Menz, Beverley Shea, Peter Tugwell, Philip Helliwell, Heidi J. Siddle	5
6	Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set 2023 ·Seminars in Arthritis and Rheumatism ·(unknown), (unknown), Jasvinder A. Singh, Nicola Dalbeth, William J. Taylor, Martin A. Kennedy, (unknown), Rebecca Grainger, Peter Tugwell, Fernando Pérez-Ruiz, Cèsar Díaz‐Torné, N. Lawrence Edwards, Beverley Shea, Torkell Ellingsen, Robin Christensen, Lisa K. Stamp	4
7	Identification of outcomes in clinical studies of interventions for venous thromboembolism in non‐pregnant adults: A scoping review 2022 ·Journal of Thrombosis and Haemostasis ·Tobias Tritschler, Ellen Cusano, Nicole Langlois, (unknown), Brian Hutton, Beverley Shea, Risa Shorr, Leslie Skeith, Lisa Duffett, (unknown), (unknown), (unknown), (unknown), Peter Tugwell, Grégoire Le Gal	9
8	Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties equity table 2022 ·Seminars in Arthritis and Rheumatism ·Cheryl Barnabé, (unknown), Jennifer Petkovic, Dorcas Beaton, Beverley Shea, Regina Greer-Smith, Jennifer Humphreys, Christie M. Bartels, Peter Tugwell, (unknown)	4
9	Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group 2021 ·Seminars in Arthritis and Rheumatism ·(unknown), Thasia Woodworth, Niti Goel, John P. A. Ioannidis, Peter Tugwell, (unknown), Paula Williamson, Caroline B. Terwee, María E. Suarez‐Almazor, Vibeke Strand, Amye Leong, Philip G. Conaghan, Maarten Boers, Beverley Shea, Peter Brooks, Lee S. Simon, Daniel E. Furst, Robin Christensen	2
10	Combination Tests in the Diagnosis of Chronic Periprosthetic Joint Infection 2020 ·Journal of Bone and Joint Surgery ·Hesham Abdelbary, Wei Cheng, Nadera Ahmadzai, Alberto Carli, Beverley Shea, Brian Hutton, Dean Fergusson, Paul E. Beaulé	8
11	Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group 2020 ·Annals of the Rheumatic Diseases ·Sabrina Mai Nielsen, (unknown), Torkell Ellingsen, Beverley Shea, George A. Wells, Vivian Welch, Daniel E. Furst, Maarten de Wit, Marieke Voshaar, Carsten Bogh Juhl, Maarten Boers, Reuben Escorpizo, Thasia Woodworth, Annelies Boonen, Henning Bliddal, Lyn March, Peter Tugwell, Robin Christensen	4
12	Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study 2020 ·The Journal of Rheumatology ·Max Yates, Claire Owen, Sara Müller, (unknown), Lorna Neill, Helen Twohig, Maarten Boers, Mar Pujades‐Rodríguez, Susan M. Goodman, Jonathan T. L. Cheah, Christian Dejaco, Chetan Mukhtyar, Berit Dalsgaard Nielsen, Joanna Robson, (unknown), Beverley Shea, Sarah Mackie, Catherine Hill	7
13	OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies 2019 ·The Journal of Rheumatology ·Maarten Boers, Dorcas Beaton, Beverley Shea, Lara Maxwell, Susan J. Bartlett, Clifton O. Bingham, Philip G. Conaghan, Maria Antonietta D’Agostino, Maarten de Wit, Laure Gossec, Lyn March, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells, Peter Tugwell	81
14	Introduction 2019 ·The Journal of Rheumatology ·Lyn March, Bethan Richards, Michael Gill, Peter Brooks, Beverley Shea, Dorcas Beaton, Lara Maxwell, Sean Tunis, (unknown), Peter Tugwell	2
15	Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development 2019 ·The Journal of Rheumatology ·Susan Humphrey‐Murto, Richard Crew, Beverley Shea, Susan J. Bartlett, Lyn March, Peter Tugwell, Lara Maxwell, Dorcas Beaton, (unknown), Maarten de Wit	19
16	Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion 2019 ·The Journal of Rheumatology ·Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. Bingham, Vivian P. Bykerk, (unknown), (unknown), (unknown), Marita Cross, Peter Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen, Susan J. Bartlett	9
17	The 66/68 Joint Count for the Measurement of MSK Disease Activity/Peripheral Joint Activity in Psa: A Grappa-Omeract Working Group Initiative 2018 ·Arthritis & Rheumatism ·Alí Duarte‐García, Lihi Eder, Niti Goel, Robin Christensen, Maarten de Wit, Oliver FitzGerald, Dafna D. Gladman, (unknown), Ying Ying Leung, Colin R. Lindsay, N. McHugh, Philip J. Mease, (unknown), Beverley Shea, (unknown), William Tillett, Laura C. Coates, Alexis Ogdie	1
18	Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women 2008 ·Cochrane Database of Systematic Reviews ·George A. Wells, Ann Cranney, Joan Peterson, Michel Boucher, Beverley Shea, Vivian Welch, Doug Coyle, Peter Tugwell	158
19	Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women 2008 ·Cochrane Database of Systematic Reviews ·George A. Wells, Ann Cranney, Joan Peterson, Michel Boucher, Beverley Shea, Vivian Welch, Doug Coyle, Peter Tugwell	388
20	Cyclosporine for treating rheumatoid arthritis 1998 ·Cochrane Database of Systematic Reviews ·George A. Wells, Didier Haguenauer, Beverley Shea, María E. Suarez‐Almazor, Vivian Welch, Peter Tugwell, Joan Peterson	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact